A Phase 2 Open-Label, Single-Arm, Multicenter Study of KYV-101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects with Treatment Refractory Stiff Person Syndrome (KYSA-8)
Details
Age
Adult
Locations
Brain Imaging Center (BIC) - Scan Read
Department Specific Free Standing Clinic
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Amanda Piquet
Study ID
Protocol Number: 24-1330
More information available at ClinicalTrials.gov: NCT06588491
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers